Back to News
investment

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

Seeking Alpha
Loading...
2 min read
1 views
0 likes
VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

Summarize this article with:

SA Transcripts157.39K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call December 17, 2025 8:30 AM EST Company Participants David Domzalski - CEO, President & DirectorRebecca Frey Conference Call Participants John Fraunces - Lifesci Advisors, LLC Presentation Operator Good morning, and welcome to the VYNE Therapeutics conference call to discuss the merger of VYNE and Yarrow Bioscience. This call is being recorded for replay at the company's request. It's now my pleasure to turn the call over to John Fraunces, Director, Corporate Communications for LifeSci Advisors. Please go ahead, John. John FrauncesLifesci Advisors, LLC Good morning, and thank you for joining us for today's conference call. The link to this webcast is on the Investors page of the VYNE Therapeutics corporate website. Before we begin, I would like to remind you that our call today will include remarks about future expectations, plans and prospects for VYNE and Yarrow, which constitute forward-looking statements for the purpose of the safe harbor provisions under applicable federal securities laws. These forward-looking statements include, without limitation, statements regarding the proposed merger and other contemplated transactions. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expected, including those listed at the bottom of the press release that was released this morning. Please note, as outlined on the press release that you're advised to read when available, VYNE's filings with the SEC include a registration statement that will contain a proxy statement and a prospectus because these documents will contain important information about the transaction and the participants' interest in such transaction. These documents can be obtained without charge at the SEC's Internet website, www.sec.gov. I'll now turn the conference over to Dave Domzalski, President and Chief Executive Officer of VYNE. David DomzalskiCEO, President & Director

Read Original

Source Information

Source: Seeking Alpha